Want to see HK:3860 full AI Analyst Report?
Top Page
EPS Creative Health Technology Group Limited
(3860)
Select Model
Select Model
Rating:51Neutral
Price Target:
HK$0.60
â–¼(-4.29% Downside)
Action:Reiterated
Date:08/29/26
The score is held back primarily by uneven financial performance (return to net losses and volatile revenue), partially offset by improved balance-sheet leverage and a better 2026 cash-flow profile. Technicals add additional pressure with price below key moving averages and negative MACD, while valuation remains challenging due to losses (negative P/E) and only a modest dividend yield.
Positive Factors
Lower Leverage
Materially lower leverage reduces balance-sheet strain and improves financial flexibility. A sizable equity base gives the company greater capacity to absorb operating volatility, support ongoing operations, and pursue priorities without relying as heavily on debt financing.
Negative Factors
Revenue Volatility
The sharp swings in revenue make the company’s growth trajectory difficult to predict over the next several quarters. Uneven top-line performance can weaken operating leverage, complicate planning, and make it harder to sustain investment or build dependable earnings power.
Read all positive and negative factors
Positive Factors
Negative Factors
Lower Leverage
Materially lower leverage reduces balance-sheet strain and improves financial flexibility. A sizable equity base gives the company greater capacity to absorb operating volatility, support ongoing operations, and pursue priorities without relying as heavily on debt financing.
Read all positive factors
EPS Creative Health Technology Group Limited (3860) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$337.81M
Dividend Yield1.72%
Average Volume (3M)15.50K
Price to Earnings (P/E)―
Beta (1Y)0.25
Revenue Growth-15.95%
EPS Growth-135.81%
CountryHK
Employees133
SectorConsumer Cyclical
Sector Strength84
IndustryApparel - Retail
Share Statistics
EPS (TTM)-0.03
Shares Outstanding582,429,800
10 Day Avg. Volume26,000
30 Day Avg. Volume15,500
Financial Highlights & Ratios
PEG Ratio0.15
Price to Book (P/B)2.71
Price to Sales (P/S)0.63
P/FCF Ratio11.44
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
EPS Creative Health Technology Group Limited Business Overview & Revenue Model
Company Description
EPS Creative Health Technology Group Limited functions as an investment holding company with diverse operations. It specializes in comprehensive apparel supply chain management, serving clients across Hong Kong, mainland China, Japan, the United S...
How the Company Makes Money
null...
EPS Creative Health Technology Group Limited Financial Statement Overview
Summary
Income Statement
42
Neutral
Balance Sheet
70
Positive
Cash Flow
55
Neutral
| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 457.65M | 544.52M | 644.62M | 452.91M | 519.95M |
| Gross Profit | 75.02M | 94.58M | 99.26M | 67.85M | 76.78M |
| EBITDA | 17.63M | 57.53M | -2.96M | -37.88M | -14.53M |
| Net Income | -13.85M | 38.59M | -22.07M | -45.74M | -22.60M |
Balance Sheet | |||||
| Total Assets | 311.39M | 336.85M | 429.88M | 227.49M | 248.92M |
| Cash, Cash Equivalents and Short-Term Investments | 130.49M | 135.69M | 131.51M | 131.47M | 208.14M |
| Total Debt | 4.45M | 57.22M | 11.45M | 73.61M | 9.14M |
| Total Liabilities | 158.67M | 174.33M | 291.70M | 135.85M | 122.22M |
| Stockholders Equity | 105.91M | 120.68M | 65.36M | 87.64M | 131.32M |
Cash Flow | |||||
| Free Cash Flow | 25.11M | -23.63M | -33.60M | -40.52M | 9.99M |
| Operating Cash Flow | 28.21M | -17.92M | -28.57M | -38.11M | 10.05M |
| Investing Cash Flow | -2.98M | 57.20M | -20.40M | -11.38M | 4.57M |
| Financing Cash Flow | -37.51M | -16.78M | 33.66M | -27.75M | 98.11M |
EPS Creative Health Technology Group Limited Technical Analysis
Negative
0.63
Price Trends
0.59
Negative
0.59
Negative
0.60
Negative
Market Momentum
>-0.01
Positive
44.70
Neutral
68.38
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3860, the sentiment is Negative. The current price of 0.63 is above the 20-day moving average (MA) of 0.59, above the 50-day MA of 0.59, and above the 200-day MA of 0.60, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 44.70 is Neutral, neither overbought nor oversold. The STOCH value of 68.38 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:3860.
EPS Creative Health Technology Group Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$1.18T | 42.61 | 20.26% | 0.79% | 11.14% | 19.43% | |
72 Outperform | HK$2.01B | 9.87 | 10.15% | 10.52% | -2.94% | -6.03% | |
69 Neutral | HK$2.81B | 5.99 | 8.44% | 8.55% | -4.39% | -12.10% | |
68 Neutral | HK$9.51B | 6.36 | 12.21% | 7.80% | 10.47% | -8.83% | |
66 Neutral | HK$6.85B | 5.36 | 13.22% | 22.96% | -3.43% | -0.67% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
51 Neutral | HK$337.81M | -21.89 | -12.65% | 1.72% | -15.95% | -135.81% |
* Consumer Cyclical Sector Average
HK:3860
EPS Creative Health Technology Group Limited
0.58
-0.14
-19.44%
HK:0709
Giordano International
1.25
-0.10
-7.71%
HK:1368
Xtep International Holdings
3.53
-1.71
-32.63%
HK:3709
EEKA Fashion Holdings Limited
4.10
-3.29
-44.53%
HK:6110
Topsports International Holdings Limited
1.11
-1.48
-57.20%
HK:6288
Fast Retailing Co Ltd Shs Unsponsored Hong Kong Depositary Receipt Repr 1/100th Sh
36.84
8.84
31.57%
EPS Creative Health Technology Group Limited Corporate Events
EPS Creative Health Technology Faces Governance Gap After Independent Director Resigns
Oct 9, 2026
EPS Creative Health Technology Group Limited announced the resignation of independent non-executive director Mr. Choi Koon Ming, effective 9 October 2026, as he seeks to focus on other business commitments. His departure also ends his roles as cha...
EPS Creative Health Technology Updates Board and Committee Structure
Oct 9, 2026
EPS Creative Health Technology Group Limited has detailed the composition of its board of directors, naming six executive directors, one non-executive director and three independent non-executive directors. The leadership team spans core functions...
EPS Creative Health Issues Profit Warning on Rising Losses and Margin Pressure
Oct 2, 2026
EPS Creative Health Technology Group Limited has warned that it expects a higher loss after tax of about HK$8 million to HK$12 million for the six months ended 30 September 2026, compared with the same period a year earlier. The board attributes t...
EPS Creative Health Tech’s Controlling Shareholder to Sell 22% Stake While Retaining Control
Sep 9, 2026
EPS Creative Health Technology Group Limited has announced that controlling shareholder EPS Holdings, Inc. has agreed to sell up to 130 million shares, or 22.32% of the company’s issued share capital, to Hong Kong‑based Wisdoms Group I...
EPS Creative Health Technology Wins Shareholder Approval for 2026 Framework Purchase Deal
Jul 31, 2026
Independent shareholders of EPS Creative Health Technology Group Limited have approved the 2026 Framework Purchase Agreement and its annual caps for the three financial years ending 31 March 2029. The resolution passed unanimously by poll at an ex...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.